scholarly article | Q13442814 |
P356 | DOI | 10.1089/THY.2000.10.521 |
P698 | PubMed publication ID | 10907999 |
P2093 | author name string | Weissel M | |
Hauff W | |||
P433 | issue | 6 | |
P921 | main subject | liver failure | Q970208 |
eye disease | Q3041498 | ||
P304 | page(s) | 521 | |
P577 | publication date | 2000-06-01 | |
P1433 | published in | Thyroid | Q15709940 |
P1476 | title | Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease | |
P478 | volume | 10 |
Q38784922 | Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy. |
Q26827429 | Acute thyroid eye disease (TED): principles of medical and surgical management |
Q38877933 | Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy |
Q36216631 | An update on medical management of Graves' ophthalmopathy |
Q46542938 | Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves. |
Q34774478 | Graves' ophthalmopathy: a rational approach to treatment |
Q58695115 | Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients with Graves' Orbitopathy |
Q92341018 | Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves' orbitopathy |
Q35843262 | Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy |
Q91973934 | Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review |
Q55283252 | Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients. |
Q35582456 | Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature |
Q36799086 | Management of Graves' ophthalmopathy |
Q42283354 | Methimazole-induced liver injury overshadowed by methylprednisolone pulse therapy: Case report. |
Q35785158 | Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy |
Q30883875 | Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy |
Q41844069 | Pulse dexamethasone therapy versus pulse methylprednisolone therapy for treatment of Graves's ophthalmopathy |
Q36349128 | Safety Profile and Effects of Pulsed Methylprednisolone on Vital Signs in Thyroid Eye Disease |
Q39552770 | Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy. |
Q34014090 | The eye and thyroid disease |
Q90496708 | Therapeutic Effect of Guggulsterone in Primary Cultured Orbital Fibroblasts Obtained From Patients with Graves' Orbitopathy |
Q44286473 | Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone: a comparison of two dosing regimens |
Q50072191 | [Driving competency after combined treatment with methylprednisolone and orbital radiotherapy for endocrine orbitopathy]. |
Search more.